Article Text

See original article:

Download PDFPDF
Oxygen therapy for infants with chronic lung disease
  1. S Kotecha1,
  2. J Allen2
  1. 1Department of Child Health, University of Leicester, Leicester LE2 7LX, UK
  2. 2Division of Pulmonary Medicine and Cystic Fibrosis Center, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  1. Correspondence to:
    Dr Kotecha, Department of Child Health, University of Leicester, Leicester LE2 7LX, UK;


Supplemental oxygen is a safe and effective treatment for infants with established chronic lung disease who are not at risk of further progression of retinopathy of prematurity (ROP). Oxygen saturations of < 92% should be avoided and a target range of at least 94–96% aimed for. The saturation target range for very preterm infants at risk of developing ROP is more controversial, but the therapeutic index is probably considerably narrower.

  • chronic lung disease
  • oxygen therapy
  • retinopathy of prematurity
  • premature
  • lung
  • CLD, chronic lung disease
  • ROP, retinopathy of prematurity

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health